RetaCalc
Protocol library
SingleNot ApprovedMixedLow confidenceSourced

Glutathione

An endogenous antioxidant studied in several oral and intravenous settings. Evidence is highly route- and indication-specific and does not validate subcutaneous research vials.

Evidence context, not a personal protocol

Quantities below reproduce their stated source context—label, human study, laboratory work or educational guide. They do not assess suitability, product equivalence or individual risk.

Community-reported schedule

Community-reported · not a validated schedule

Community dose schedule

A community-provenance injectable line from forum reports - roughly 100-200 mg daily subcutaneously or intramuscularly, with a lighter 400-600 mg weekly NAD+ adjunct also described. Community reports only, not a validated schedule.

Evidence source
Reported maximum quantity
Standalone daily (forum)
Choose the maximum quantity reported by this community line. Any earlier phase can be selected below for its arithmetic.

Reported quantities by phase

Select a point for its calculation examples
  1. Starting (SubQ or IM)
    100 mg
    Standalone wellness reports begin around 100 mg; product is usually a ready-to-inject 200 mg/mL liquid, not a reconstituted powder.
  2. Steady (SubQ or IM)
    200 mg
    +100 mg
    Intramuscular delivery is often preferred; a lighter 400-600 mg weekly NAD+ adjunct across 4-5 injections is also described.

Vial-aware arithmetic

Reconstitution examples, up to 3 mL

Choose the vial quantity and BAC water first. The diagram and results below update for the selected 100 mg reported quantity. Higher-strength vials may naturally land outside the 20-30 unit band.

Vial quantity

Choose the quantity printed on the vial.

BAC water added

Use 1, 2 or 3 mL, or enter a custom volume up to 3 mL.

Open the full reverse calculator
Three millilitre research vial, diluent vial and capped U-100 syringe on an ink-blue surface
One small vial, one measured diluent volume and one U-100 scale. The arithmetic connects all three.
BAC water selected
1 mL

Basic example limit: 3 mL maximum. Check the actual vial and product-specific limits.

1 mL BAC
16.667 units

resulting U-100 draw

Concentration
600 mg/mL
BAC added
1 mL

Shown in the diagram. Closest of these examples to 25 units.

2 mL BAC
33.333 units

resulting U-100 draw

Concentration
300 mg/mL
BAC added
2 mL
3 mL BAC
50 units

resulting U-100 draw

Concentration
200 mg/mL
BAC added
3 mL

Formula: draw units = selected mg × BAC mL ÷ vial mg × 100. The 20-30 unit band is a measurement reference, not a recommendation. Results are mathematical examples, not preparation instructions.

Dosage and protocol evidence

Each card states what the quantities are based on. A third-party or animal schedule is not a validated human dose.

Community GuideSubcutaneous in guideDaily
Third-party educational schedule for a 600 mg vial

100 mg daily in weeks 1-2, 150 mg in weeks 3-4 and 200 mg in weeks 5-8

The guide presents subcutaneous research-vial use, whereas human clinical literature is heterogeneous and largely uses other routes. It is not a validated universal schedule.

View source
Community GuideIntravenous, subcutaneous or oral in reportsDaily to twice weekly depending on route
online research community summaries and reports

The channel states 200-600 mg daily across routes, 600-1,200 mg intravenously once or twice weekly, or 100 mg subcutaneously six days weekly for 4-8 weeks

Those statements conflict with the same post's asserted 1,200 mg weekly ceiling. Route effectiveness and cycling are also disputed; raw/peptide-education/pe-glutathione.md:18-31 and 41-62.

View source
Community GuideSubcutaneous or intramuscular in reportsDaily to a few times weekly depending on pattern
authenticated research-forum (Peppys) reports

Subcutaneous or intramuscular quantities split into two patterns, a standalone wellness dose around 100-200 mg daily (some run 200-600 mg two to three times weekly) and a lighter NAD+ adjunct near 400-600 mg weekly (own protocol 500 mg, cited maximum about 1,100 mg weekly) across four to five injections; many prefer intramuscular delivery and buffer or add lidocaine because straight glutathione stings

Forum provenance from an authenticated archive with usernames omitted. Product is usually a ready-to-inject 200 mg/mL liquid rather than a reconstituted powder, quantities conflict, and one adverse report followed 400 mg intramuscularly in a single injection. The subcutaneous, intramuscular, oral and intravenous routes are kept separate. Community provenance, not controlled human dose finding.

View source

Evidence summary

An endogenous antioxidant studied in several oral and intravenous settings. Evidence is highly route- and indication-specific and does not validate subcutaneous research vials.

Protocol basis

Rather than collapsing different formulations into one dose, this page anchors the evidence to route-specific human studies and withholds a universal protocol.

Community provenance (Peppys)

An authenticated research-forum archive records injectable glutathione in two patterns: a standalone wellness dose around 100-200 mg daily subcutaneously or intramuscularly, and a lighter NAD+ adjunct near 400-600 mg weekly across four to five injections, with a cited ceiling around 1,100 mg weekly. Many reports prefer intramuscular delivery and buffer the solution or add lidocaine because straight glutathione stings, and one adverse reaction followed 400 mg intramuscularly in a single injection. Quantities conflict, the subcutaneous, intramuscular, oral and intravenous routes are kept separate, and usernames are omitted with figures logged as community provenance without endorsement. The planner above reproduces the arithmetic of the daily subcutaneous or intramuscular reports only and does not validate them.

What remains uncertain

No single schedule generalises across indications, routes or compounded preparations, and subcutaneous vial evidence is especially sparse.

Warnings and contraindications

Oral, intravenous, inhaled and topical glutathione findings are not interchangeable.
Injection products require route-specific sterility, compatibility and clinical oversight.
Broad detoxification or anti-ageing claims exceed the cited evidence.
The online research community summary gives internally conflicting daily and weekly ceilings and should not be treated as a coherent schedule.
Organised research bench with labelled storage tray, vial rack, notebook and thermometer
A clean workspace supports traceability. It does not establish sterility.

Shared across protocols

Supplies and general handling

Keep the universal checklist short. Product-specific labelling and source documentation always take priority over a general guide.

Research vial

Select the labelled vial quantity used in the calculation.

View Peppys vial

Bacteriostatic water

Use only a diluent appropriate to the research method and formulation.

View Peppys BAC water

U-100 measuring syringe

Use a new sterile device for every entry. Source locally.

Source locally

Wipes and sharps container

Plan clean handling and immediate sharps disposal. Source locally.

Source locally

Storage follows the label

Do not apply a universal refrigerator rule. Follow the product, diluent and study documentation for temperature, light and expiry.

Use sterile equipment once

CDC injection-safety guidance calls for a new sterile needle and syringe for each injection and entry into a medication container.

Stability is formulation-specific

Do not infer a post-mixing lifetime from BAC water alone. Discard material when identity, integrity or sterility is in doubt.

General references: CDC injection safety, NHS medicine storage and DailyMed BAC water labelling.